ArticleBriefings in bioinformatics2026
STED: flexible cross-modal topic modeling infers cell-type-specific regulatory landscapes from bulk epigenomics.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Deciphering cell-type-specific epigenetic landscapes within heterogeneous tissues is restricted by the sparsity, high cost, and limited throughput of current single-cell epigenomic technologies. To bridge the gap between massive legacy bulk epigenomic data and cellular resolution, we present STED (Single-cell Topic modeling and Epigenetic deconvolution), a flexible computational framework that reconstructs cell-type-specific regulatory signals by leveraging single-cell transcriptomic references. Methodologically, STED introduces a versatile topic modeling architecture: users can employ the information-theoretic correlation explanation algorithm to robustly mitigate transcriptomic sparsity, or innovatively adapt BERTopic-a large language model-based framework-to capture high-dimensional semantic cellular states. STED couples these latent regulatory topics with a physics-based "gene activity score" transformation, which acts as a cross-modal bridge to deconvolve bulk chromatin accessibility (ATAC-seq) and histone modification (ChIP-seq/CUT&Tag) profiles. Extensive benchmarking across diverse datasets-including human peripheral blood mononuclear cells (PBMCs), mouse brain, and zebrafish inner ear-demonstrates that STED significantly outperforms existing rigid-reference tools in accuracy and robustness against cross-platform batch effects. In a hematopoietic stem cell differentiation model, STED successfully identifies cell-type-specific transcription factor binding motifs and differential peaks associated with lineage commitment. We further demonstrate STED's biological utility by uncovering tumor-specific super-enhancers in colorectal cancer-a mechanism obscured in bulk signals. STED thus provides a scalable, foundation-model-empowered solution for dissecting gene regulatory networks in complex tissues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.